Weblog met nieuws over de pharmaceutische industrie
27 Jun
ThromboGenics NV (Euronext Brussels: THR), a biotechnology company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, announces that its lead product microplasmin, which is in Phase III trials for the treatment of vitreomacular adhesion, is progressing according to schedule. All protocol-specified, interim masked analyses by the independent Data Monitoring Committee (DMC) have been completed.
Lees meer..
27 Jun
Insmed Inc. (Nasdaq: INSM), a biopharmaceutical company, announced results from its exploratory U.S. Phase II clinical trial evaluating IPLEX(TM) (mecasermin rinfabate) in patients with myotonic muscular dystrophy (”MMD”). The randomized, double-blind, placebo-controlled Phase II trial conducted in 13 centers across the U.S. enrolled 69 patients with MMD, for a six-month period. As this was an exploratory trial, a primary endpoint was not pre-defined.
Lees meer..
27 Jun
Sanofi Pasteur, the vaccines division of the sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), announced that the company has been able to increase the supply of its Hib-containing vaccines to enable the return to a full series of vaccinations for U.S. children. Based on the increased supply, on July 1, the U.S.
Lees meer..
27 Jun
An important resource consolidating understanding of the roles played by Ion channels in drug action is now available for scientists and students. The International Union of Basic and Clinical Pharmacology (IUPHAR) announce the publication of a new ion channels database, covering both the voltage-gated (VGIC) and ligand-gated (LGIC) ion channels.
Lees meer..
27 Jun
Furthering its mission to improve the quality of medicines worldwide, the U.S. Pharmacopeial (USP) Convention has signed a cooperative agreement with nine countries belonging to the Association of Southeast Asian Nations (ASEAN).
Lees meer..
27 Jun
27 Jun
A flat income tax plan that is part of budget plans being crafted by the Arizona Legislature and Gov. Jan Brewer would take Arizona’s five personal income tax brackets down to one rate of between 2.6 percent and 3 percent and substantially cut corporate income tax rates.
27 Jun
Calling it a “generous compromise” between plans laid out by powerful Rep. Henry Waxman (D-Los Angeles) and Peninsula Democratic Rep. Anna Eshoo, the Obama administration said biogeneric drugs should be protected from competition for seven years.
27 Jun
27 Jun